Without Guidelines, Docs Make Their Own Long COVID Protocols
SOURCES:
American Academy of Physical Medicine and Rehabilitation: “PASC Dashboard.”
Janna Friedly, MD, executive director, Post-COVID Rehabilitation and Recovery Clinic, University of Washington.
National Institutes of Health: “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines,” “RECOVER: Researching COVID,” “RECOVER Program Takes First Steps in Advancing Toward Clinical Trials to Better Understand Long COVID.”
Cancer: “Prevalence and Characteristics of Moderate to Severe Fatigue: A Multicenter Study in Cancer Patients and Survivors.”
National Institute for Health Care and Excellence: “Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management.”
Monica Verduzco-Gutierrez, MD, chair of rehabilitation medicine, director, COVID-19 Recovery Clinic, University of Texas Health Science Center at San Antonio.
PM&R: “Multidisciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Fatigue in Postacute Sequelae of SARS-CoV-2 infection (PASC) Patients.”
The Journal of Head Trauma Rehabilitation: “Effectiveness of Amantadine Hydrochloride in the Reduction of Chronic Traumatic Brain Injury Irritability and Aggression.”
CNS Drugs: “Modafinil: A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.”
Frontiers in Neurology: “Methylphenidate Treatment of Cognitive Dysfunction in Adults After Mild to Moderate Traumatic Brain Injury: Rationale, Efficacy, and Neural Mechanisms.”
PM&R: “Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Cognitive Symptoms in Patients With Post-Acute Sequelae of SARS-CoV-2 Infection (PASC).”
Annals of Clinical and Translational Neurology: “Persistent Neurologic Symptoms and Cognitive Dysfunction in Non-Hospitalized Covid-19 Long Haulers.”
Alba Miranda Azola, MD, co-director, Post-Acute COVID-19 Team, Johns Hopkins University School of Medicine, Baltimore.
U.S. National Library of Medicine: “SARS-CoV-2 Viral Persistence Study (PASC) – Study of Long COVID-19.”
PolyBio: “LongCovid Research Consortium.”
Gary H. Gibbons, MD, director, National Heart, Lung, and Blood Institute.
